增强剂相关的LncRNA-ITGA2通过ITGA2促进血管重塑
Xian Guo1,2, Pan Hou1,3, Sha Zhang1
1Department of Cardiology, Changhai Hospital, Naval Medical University, Shanghai, China. (X.G., P.H., S.Z., Q.X., M.Z., W.T., B.Z., Z.G., X.Z., P.L.).
Circulation research
|May 5, 2025
概括
这项研究确定增强剂相关的长非编码RNA-ITGA2 (LncRNA-ITGA2) 是血管光滑肌肉细胞增殖和迁移的关键驱动因素. 通过与NONO相互作用来增强ITGA2基因表达,LncRNA-ITGA2促进了血管重塑.
科学领域:
- 血管生物学 血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 疾病的分子机制.
背景情况:
- 血管光滑肌细胞 (VSMC) 的增殖和迁移在血管重塑中至关重要.
- 增强剂相关的长非编码RNAs (elncRNAs) 与细胞命运有关,但它们在VSMC功能障碍中的作用尚不清楚.
研究的目的:
- 识别和描述涉及VSMC功能障碍的新型elncRNAs.
- 阐明elncRNAs在血管重塑中的调节机制.
主要方法:
- 多基因分析 (CUT&Tag,Hi-C,微阵列) 用于识别LncRNA-ITGA2.2.
- 在体外的动脉电线损伤模型和体外的VSMC培养.
- 通过RNA测序,CRISPR-Cas9,ChIP-seq,ChIRP和RIP来研究它们的机制.
主要成果:
- 在增殖性VSMC和动脉样硬化组织中,LncRNA-ITGA2被上调.
- 对LncRNA-ITGA2的过度表达促进了VSMC的增殖,迁移和新极端增生.
- LncRNA-ITGA2通过促进增强剂-促进剂相互作用和依赖NONO的H3K27乙化来增强ITGA2的表达.
结论:
- LncRNA-ITGA2通过一种非依赖性机制促进VSMC的增殖和迁移,将增强剂-ITGA2和促进剂-ITGA2联系起来.
- 这种elncRNA是扩散性血管疾病的潜在诊断和治疗点.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
01:10Mechanism of Angiogenesis
5.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.0K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K